MedPath

Efficacy of Transcranial Magnetic Stimualtion in relieving symtooms in Parkinsons Disease.

Not Applicable
Conditions
Health Condition 1: null- Parkinsons DiseaseHealth Condition 2: G20- Parkinsons disease
Registration Number
CTRI/2018/01/011563
Lead Sponsor
All India Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia);

2.PD patients of both gender with H&Y stage from 1 to 2.

3.PD patients between age 45 to 75 on stable medication for at least 30 days

Exclusion Criteria

1.Features suggestive of other causes of Parkinsonism/ Parkinson-plus syndromes;

2.History of surgery on brain for any indication, significant headaches, epilepsy or seizure disorder, mass lesions, or major head trauma leading to loss of consciousness of any length;

3.Family (1st degree relatives) history of epilepsy;

4.History of schizophrenia, schizoaffective disorder, other psychosis, claustrophobia; rapid-cycling bipolar illness, alcohol/drug abuse within the past year;

5.Need for rapid clinical response due to conditions such as psychosis, or suicide tendency;

6.Patients with uncontrolled hypertension and diabetes and other uncontrolled medical illness. Patients with hypertension or diabetes would be included only if they are stable on medication for last six months.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i.To compare the status of cortical plasticity between two treatment groups (M1, SMA) using FDG-PET. <br/ ><br>Timepoint: Baseline 0 day <br/ ><br>Post Sham at 4th week <br/ ><br>Post Real at 8th week <br/ ><br>[Baseline:-After recruitment <br/ ><br>Post-Sham:-After 4 sessions of Sham TMS <br/ ><br>Post-Real:- After 4 sessions of Real TMS.]
Secondary Outcome Measures
NameTimeMethod
To compare the clinical condition of the patients in the two treatment groups on the basis of UPDRS. <br/ ><br>Timepoint: Baseline 0 day <br/ ><br>Post Sham at 4th week <br/ ><br>Post Real at 8th week <br/ ><br>[Baseline:-After recruitment <br/ ><br>Post-Sham:-After 4 sessions of Sham TMS <br/ ><br>Post-Real:- After 4 sessions of Real TMS.]
© Copyright 2025. All Rights Reserved by MedPath